Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil doesn't affect blood pressure in patients taking blood pressure meds.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Semaglutide does not significantly increase the risk of hair loss.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

JAK inhibitors may reduce depression in people with alopecia areata.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Integrating biological networks improves drug repurposing and ADR prediction.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

Biotrinine® may be an effective treatment for chronic hair loss.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

Cardiac xenotransplantation is moving towards clinical use with growing research and collaboration.